-
08:00-08:45 - Auditorium
45 min
Short Oral Communications
Autoimmune Diseases (2); Autoinflammatory Diseases (1); Systemic Erythematosus Lupus (1); Rheumatoid Arthritis (1)
ChairsMaria De Fátima Graça Farinha
ChairsMaria Teresa Faria De Mendonça
ChairsÁlvaro Matos Soares Ferreira
AuthorYeika Larrinaga
CO02 - (1772) - ACQUIRED HEMOPHILIA A PRESENTING AS A THIGH INTRAMUSCULAR HEMATOMA
AuthorAntónio Lamas
CO13 - (2191) - PULMONARY ARTERIAL HYPERTENSION AS A MANIFESTATION OF STILL'S DISEASE
AuthorInês Alves
CO04 - (2182) - ANTI-GLYCAN AUTOANTIBODIES REVEAL GLYCAN MIMICRY IN LUPUS
AuthorCarolina Salteiro
CO05 - (2183) - ANTI PLA2R: TWO METHODS – ALTERNATIVE OR COMPLEMENTARY
AuthorCátia Baptista
CO06 - (2184) - RHEUMATOID MENINGOENCEPHALITIS: FOCAL MOTOR STATUS EPILEPTICUS IN RAMaria De Fátima Graça Farinha
Maria Teresa Faria De Mendonça
Álvaro Matos Soares Ferreira
Yeika Larrinaga
António Lamas
Inês Alves
Carolina Salteiro
Cátia Baptista
-
09:00-09:30 - Auditorium
30 min
REDEFINING AUTOIMMUNITY: SYSTEMS, SIGNALS, AND SHIFTS
Opening Keynote - Autoimmunity Beyond Disease: A Systems Biology Perspective
ChairManuel João Rua Vilanova
SpeakerIoannis Parodis
Manuel João Rua Vilanova
Ioannis Parodis
Ioannis Parodis studied medicine at the National and Kapodistrian University of Athens, Greece, and graduated in 2006. He has an interest in B cell biology and novel treatments for systemic lupus erythematosus and lupus nephritis. His research focuses on identifying biomarkers and calibrating predictive models for diagnostics, clinical and immune responses to therapies, and long-term prognosis in systemic lupus erythematosus (SLE) and lupus nephritis (LN).
Currently, Ioannis Parodis holds a permanent position as a senior consultant rheumatologist at the Karolinska University Hospital in Stockholm, Sweden, and educational leadership positions at the medical programme of Karolinska Institutet. Along with clinical work and teaching, Ioannis Parodis conducts clinical and translational research within the field of inflammation and autoimmunity at the Karolinska Institutet. Since 2021, Ioannis Parodis is also affiliated to the Örebro University, Örebro, Sweden.
Ioannis Parodis is leading a research team at the Center for Molecular Medicine (CMM) in Region Stockholm, and is currently the main supervisor of four doctoral students and co-supervisor of two. He serves as the global PI for ReBioLup (NCT04449991; http://rebiolup.com) and the PI for prospective studies at the Karolinska and Örebro University Hospitals, including SLE studies conducted within the frame of the European 3TR project. He has contributed to EULAR task forces for the development of recommendations for the management of SLE and LN, as well as recommendations for the non-pharmacological management of SLE and systemic sclerosis. -
09:30-11:00 - Auditorium
90 min
REDEFINING AUTOIMMUNITY: SYSTEMS, SIGNALS, AND SHIFTS
Session 1: Rethinking Disease Architecture
ChairsAna Campar
ChairsNatália Oliveira
ChairsCarlos Jorge Magalhães Crespo
SpeakerFrancisco Rodrigues Pinto
From Organ-Based to Network-Based DiagnosisSpeakerJosé António Pereira Delgado Alves
Are We Treating Diseases or Immune States?SpeakerAntónio Marinho
Integrating New Classification Criteria: Are We Ready for Dynamic Taxonomies?SpeakerRaquel Faria
A Clinical Look -The patient who doesn't fit into the classification: a practical approach in 2026
SpeakerAntónio Lamas
A Clinical Look -The patient who doesn't fit into the classification: a practical approach in 2026Ana Campar
Natália Oliveira
Assistente Hospitalar Graduada em Medicina Interna.
Coordenadora da Unidade de Doenças Autoimunes da ULS Tâmega e Sousa (Penafiel).
Carlos Jorge Magalhães Crespo
· AH Graduado Sénior de Medicina Interna (aposentado do CHUC em Nov/21)
· Coordenador do Grupo que fez o 1º levantamento da causuística nacional sobre DB no NEDAI – Medicina Interna 1997. 4(4):225-232
· Membro do Council da International Society for BD
Francisco Rodrigues Pinto
José António Pereira Delgado Alves
Prof. Doutor José Delgado Alves, MD, PhD
Degree in Medicine by the NOVA Medical School in Lisbon. Specialist in Internal Medicine and in Clinical Pharmacology. PhD in Medicine (Rheumatology) by the University College of London.
Director of the Internal Medicine Department 4 and of the Systemic Immunomediated Diseases Unit, Fernando da Fonseca Hospital, Amadora, Portugal.
Professor of Medicine and Medical Therapeutics at NOVA Medical School.
Principal Investigator and Coordinator of the “Immune response and Vascular Disease Research Group” of NMS Research. Coordinator of the Clinical Research and Precision Medicine Department of INova4Health.
Principal Investigator in more than 20 phase 1, 2 and 3 multicentre clinical trials. Recipient of multiple national and international research grants and awards. Author of more than 170 original papers and book chapters and supervisor of several PhD and masters students.
Past-President of the Autoimmune Diseases Study Group of the Portuguese Society of Internal Medicine. Scientific advisor for the Portuguese Health Administration Agency (DGS) and for INFARMED (Portuguese Drug Agency).
Chairman of the Expert Committee of ECRIN (European Clinical Research Infrastructure Network).
President of the European Board of Internal Medicine (EBIM).
António Marinho
Raquel Faria
António Lamas
-
11:00-11:30
30 min
Coffee-Break
-
11:30-13:00 - Auditorium
90 min
REDEFINING AUTOIMMUNITY: SYSTEMS, SIGNALS, AND SHIFTS
Session 2: Signals, Sensors, and Surveillance
ChairsSofia Correia
ChairsCarlos Filipe Gonçalves Lage Carneiro
SpeakerSabine Szunerits
Real-Time Immunology: Lessons from Wearable biosensors and remote monitoringSpeakerEdward Vital
A Clinical Look - Biomarkers and Immune Signatures in Systemic Lupus Erythematosus
Sofia Correia
Carlos Filipe Gonçalves Lage Carneiro
Coordenador do Núcleo de Doenças Autoimunes da Sociedade Portuguesa de Medicina Interna (2024-2026)
Coordenador da Unidade de Doenças Autoimunes do Grupo HPA-Saude
Assistente Convidado na Licenciatura Medicina da Universidade do Algarve
Presidente da Associação Medica do Algarve (AMALG) - AICARE Academy
Sabine Szunerits
Edward Vital
-
13:00-14:30
90 min
Lunch Break
-
14:30-14:50 - Auditorium
20 min
REDEFINING AUTOIMMUNITY: SYSTEMS, SIGNALS, AND SHIFTS
Opening Ceremony - Welcome by the Organizing Committee
SpeakersAntónio Marinho
SpeakersCarlos Vasconcelos
SpeakersHenrique Cyrne Carvalho
SpeakersPaulo Barbosa
António Marinho
Carlos Vasconcelos
Henrique Cyrne Carvalho
Paulo Barbosa
-
14:50-16:40 - Auditorium
110 min
REDEFINING AUTOIMMUNITY: SYSTEMS, SIGNALS, AND SHIFTS
Session 3: Patient-Centric Innovation
ChairJoão Araújo Correia
ChairElisabete Da Conceição Lourenço Pinelo
ChairErnestina Santos
SpeakerRosa Giuliani
PRO as Primary Endpoints: A Regulatory PerspectiveSpeakerSara Cavaco
A Clinical Look - Fatigue, Pain, Brain Fog: How Should We Measure What Matters?SpeakerAntónio Marinho
From Hospital to Home: Patient-Centric Models for Immunoglobulin TherapySpeakerCarlos Filipe Gonçalves Lage Carneiro
Clinical Controversy Clinical Hands-On A Clinical Look PROs can guide therapeutic decisions? Yes, No, dependsJoão Araújo Correia
João Araújo Correia, 16/11/59
Assistente Graduado Sénior de Medicina Interna
Diretor da Clínica de Medicina da ULSSA
Professor Associado Convidado do MIM do ICBAS/CHUdSA
Coordenador do Coorte de Doença de Behçet da UIC
Ex Presidente do Colégio Especialidade MI, Ex Presidente da SPMI,
Ex Diretor do SMI, Ex Diretor Pedagógico e Científico
Elisabete Da Conceição Lourenço Pinelo
Ernestina Santos
Rosa Giuliani
Sara Cavaco
António Marinho
Carlos Filipe Gonçalves Lage Carneiro
Coordenador do Núcleo de Doenças Autoimunes da Sociedade Portuguesa de Medicina Interna (2024-2026)
Coordenador da Unidade de Doenças Autoimunes do Grupo HPA-Saude
Assistente Convidado na Licenciatura Medicina da Universidade do Algarve
Presidente da Associação Medica do Algarve (AMALG) - AICARE Academy
-
16:40-17:00
20 min
Coffee-Break
-
17:00-17:30 - Auditorium
30 min
Clinical Immunology Quiz Race 1
-
08:00-08:45 - Auditorium
45 min
Short Oral Communications
Autoimmune Diseases (2); Autoinflammatory Diseases (1); Systemic Erythematosus Lupus (1); Rheumatoid Arthritis (1)
ChairsMaria De Fátima Graça Farinha
ChairsMaria Teresa Faria De Mendonça
ChairsÁlvaro Matos Soares Ferreira
AuthorYeika Larrinaga
CO02 - (1772) - ACQUIRED HEMOPHILIA A PRESENTING AS A THIGH INTRAMUSCULAR HEMATOMA
AuthorAntónio Lamas
CO13 - (2191) - PULMONARY ARTERIAL HYPERTENSION AS A MANIFESTATION OF STILL'S DISEASE
AuthorInês Alves
CO04 - (2182) - ANTI-GLYCAN AUTOANTIBODIES REVEAL GLYCAN MIMICRY IN LUPUS
AuthorCarolina Salteiro
CO05 - (2183) - ANTI PLA2R: TWO METHODS – ALTERNATIVE OR COMPLEMENTARY
AuthorCátia Baptista
CO06 - (2184) - RHEUMATOID MENINGOENCEPHALITIS: FOCAL MOTOR STATUS EPILEPTICUS IN RAMaria De Fátima Graça Farinha
Maria Teresa Faria De Mendonça
Álvaro Matos Soares Ferreira
Yeika Larrinaga
António Lamas
Inês Alves
Carolina Salteiro
Cátia Baptista
-
09:00-09:30 - Auditorium
30 min
REDEFINING AUTOIMMUNITY: SYSTEMS, SIGNALS, AND SHIFTS
Opening Keynote - Autoimmunity Beyond Disease: A Systems Biology Perspective
ChairManuel João Rua Vilanova
SpeakerIoannis Parodis
Manuel João Rua Vilanova
Ioannis Parodis
Ioannis Parodis studied medicine at the National and Kapodistrian University of Athens, Greece, and graduated in 2006. He has an interest in B cell biology and novel treatments for systemic lupus erythematosus and lupus nephritis. His research focuses on identifying biomarkers and calibrating predictive models for diagnostics, clinical and immune responses to therapies, and long-term prognosis in systemic lupus erythematosus (SLE) and lupus nephritis (LN).
Currently, Ioannis Parodis holds a permanent position as a senior consultant rheumatologist at the Karolinska University Hospital in Stockholm, Sweden, and educational leadership positions at the medical programme of Karolinska Institutet. Along with clinical work and teaching, Ioannis Parodis conducts clinical and translational research within the field of inflammation and autoimmunity at the Karolinska Institutet. Since 2021, Ioannis Parodis is also affiliated to the Örebro University, Örebro, Sweden.
Ioannis Parodis is leading a research team at the Center for Molecular Medicine (CMM) in Region Stockholm, and is currently the main supervisor of four doctoral students and co-supervisor of two. He serves as the global PI for ReBioLup (NCT04449991; http://rebiolup.com) and the PI for prospective studies at the Karolinska and Örebro University Hospitals, including SLE studies conducted within the frame of the European 3TR project. He has contributed to EULAR task forces for the development of recommendations for the management of SLE and LN, as well as recommendations for the non-pharmacological management of SLE and systemic sclerosis. -
09:30-11:00 - Auditorium
90 min
REDEFINING AUTOIMMUNITY: SYSTEMS, SIGNALS, AND SHIFTS
Session 1: Rethinking Disease Architecture
ChairsAna Campar
ChairsNatália Oliveira
ChairsCarlos Jorge Magalhães Crespo
SpeakerFrancisco Rodrigues Pinto
From Organ-Based to Network-Based DiagnosisSpeakerJosé António Pereira Delgado Alves
Are We Treating Diseases or Immune States?SpeakerAntónio Marinho
Integrating New Classification Criteria: Are We Ready for Dynamic Taxonomies?SpeakerRaquel Faria
A Clinical Look -The patient who doesn't fit into the classification: a practical approach in 2026
SpeakerAntónio Lamas
A Clinical Look -The patient who doesn't fit into the classification: a practical approach in 2026Ana Campar
Natália Oliveira
Assistente Hospitalar Graduada em Medicina Interna.
Coordenadora da Unidade de Doenças Autoimunes da ULS Tâmega e Sousa (Penafiel).
Carlos Jorge Magalhães Crespo
· AH Graduado Sénior de Medicina Interna (aposentado do CHUC em Nov/21)
· Coordenador do Grupo que fez o 1º levantamento da causuística nacional sobre DB no NEDAI – Medicina Interna 1997. 4(4):225-232
· Membro do Council da International Society for BD
Francisco Rodrigues Pinto
José António Pereira Delgado Alves
Prof. Doutor José Delgado Alves, MD, PhD
Degree in Medicine by the NOVA Medical School in Lisbon. Specialist in Internal Medicine and in Clinical Pharmacology. PhD in Medicine (Rheumatology) by the University College of London.
Director of the Internal Medicine Department 4 and of the Systemic Immunomediated Diseases Unit, Fernando da Fonseca Hospital, Amadora, Portugal.
Professor of Medicine and Medical Therapeutics at NOVA Medical School.
Principal Investigator and Coordinator of the “Immune response and Vascular Disease Research Group” of NMS Research. Coordinator of the Clinical Research and Precision Medicine Department of INova4Health.
Principal Investigator in more than 20 phase 1, 2 and 3 multicentre clinical trials. Recipient of multiple national and international research grants and awards. Author of more than 170 original papers and book chapters and supervisor of several PhD and masters students.
Past-President of the Autoimmune Diseases Study Group of the Portuguese Society of Internal Medicine. Scientific advisor for the Portuguese Health Administration Agency (DGS) and for INFARMED (Portuguese Drug Agency).
Chairman of the Expert Committee of ECRIN (European Clinical Research Infrastructure Network).
President of the European Board of Internal Medicine (EBIM).
António Marinho
Raquel Faria
António Lamas
-
11:30-13:00 - Auditorium
90 min
REDEFINING AUTOIMMUNITY: SYSTEMS, SIGNALS, AND SHIFTS
Session 2: Signals, Sensors, and Surveillance
ChairsSofia Correia
ChairsCarlos Filipe Gonçalves Lage Carneiro
SpeakerSabine Szunerits
Real-Time Immunology: Lessons from Wearable biosensors and remote monitoringSpeakerEdward Vital
A Clinical Look - Biomarkers and Immune Signatures in Systemic Lupus Erythematosus
Sofia Correia
Carlos Filipe Gonçalves Lage Carneiro
Coordenador do Núcleo de Doenças Autoimunes da Sociedade Portuguesa de Medicina Interna (2024-2026)
Coordenador da Unidade de Doenças Autoimunes do Grupo HPA-Saude
Assistente Convidado na Licenciatura Medicina da Universidade do Algarve
Presidente da Associação Medica do Algarve (AMALG) - AICARE Academy
Sabine Szunerits
Edward Vital
-
14:30-14:50 - Auditorium
20 min
REDEFINING AUTOIMMUNITY: SYSTEMS, SIGNALS, AND SHIFTS
Opening Ceremony - Welcome by the Organizing Committee
SpeakersAntónio Marinho
SpeakersCarlos Vasconcelos
SpeakersHenrique Cyrne Carvalho
SpeakersPaulo Barbosa
António Marinho
Carlos Vasconcelos
Henrique Cyrne Carvalho
Paulo Barbosa
-
14:50-16:40 - Auditorium
110 min
REDEFINING AUTOIMMUNITY: SYSTEMS, SIGNALS, AND SHIFTS
Session 3: Patient-Centric Innovation
ChairJoão Araújo Correia
ChairElisabete Da Conceição Lourenço Pinelo
ChairErnestina Santos
SpeakerRosa Giuliani
PRO as Primary Endpoints: A Regulatory PerspectiveSpeakerSara Cavaco
A Clinical Look - Fatigue, Pain, Brain Fog: How Should We Measure What Matters?SpeakerAntónio Marinho
From Hospital to Home: Patient-Centric Models for Immunoglobulin TherapySpeakerCarlos Filipe Gonçalves Lage Carneiro
Clinical Controversy Clinical Hands-On A Clinical Look PROs can guide therapeutic decisions? Yes, No, dependsJoão Araújo Correia
João Araújo Correia, 16/11/59
Assistente Graduado Sénior de Medicina Interna
Diretor da Clínica de Medicina da ULSSA
Professor Associado Convidado do MIM do ICBAS/CHUdSA
Coordenador do Coorte de Doença de Behçet da UIC
Ex Presidente do Colégio Especialidade MI, Ex Presidente da SPMI,
Ex Diretor do SMI, Ex Diretor Pedagógico e Científico
Elisabete Da Conceição Lourenço Pinelo
Ernestina Santos
Rosa Giuliani
Sara Cavaco
António Marinho
Carlos Filipe Gonçalves Lage Carneiro
Coordenador do Núcleo de Doenças Autoimunes da Sociedade Portuguesa de Medicina Interna (2024-2026)
Coordenador da Unidade de Doenças Autoimunes do Grupo HPA-Saude
Assistente Convidado na Licenciatura Medicina da Universidade do Algarve
Presidente da Associação Medica do Algarve (AMALG) - AICARE Academy
-
17:00-17:30 - Auditorium
30 min
Clinical Immunology Quiz Race 1
-
08:00-08:56 - Auditorium
56 min
Short Oral Communications
Autoimmune Diseases (5); Rheumatoid Arthritis (1)
ChairsBruno Grima
ChairsAndre Miguel Neto Real
ChairsTeresa Maria Melim Faria
AuthorJéssica Oliveira
CO07 - (2185) - ANTI-SAE DERMATOMYOSITIS WITH ORGANIZING PNEUMONIA IN AN ELDERLY PATIENT
AuthorCátia Baptista
CO08 - (2186) - THALAMIC ISCHEMIA IN ANTIPHOSPHOLIPID SYNDROME: A RARE PRESENTATION
AuthorCatarina Coelho Faria
CO09 - (2187) - AN UNUSUAL AUTOIMMUNE TRIAD: SLE, SJÖGREN’S DISEASE AND RELAPSING POLYCHONDRITIS
AuthorSara Dourado
CO10 - (2188) - BEYOND SARCOIDOSIS: AN UNEXPECTED DIAGNOSIS OF PRIMARY SCLEROSING CHOLANGITIS
AuthorSara Dourado
CO11 - (2189) - WHEN ELEVATED IGG4 MISLEADS: A DIAGNOSTIC ODYSSEY TO CASTLEMAN DISEASE
AuthorMafalda Santos
CO12 - (2190) - LUNG NODULES IN RHEUMATOID ARTHRITIS. A DISEASE OR A THERAPEUTIC COMPLICATION?Bruno Grima
Andre Miguel Neto Real
Assistente Hospitalar Graduado em Medicina Interna.
Assistente Hospitalar em Medicina Intensiva.
Coordenador da Unidade de Doenças Autoimunes da ULS Médio Tejo - Abrantes
Teresa Maria Melim Faria
Jéssica Oliveira
Cátia Baptista
Catarina Coelho Faria
Sara Dourado
Sara Dourado
Mafalda Santos
-
09:00-10:30 - Auditorium
90 min
PRECISION AND PREDICTION IN CLINICAL PRACTICE
Session 4: Biomarkers and digital monitoring
ChairGraziela Carvalheiras
ChairJorge Manuel Santos Fortuna
ChairAntonio Alexandre Morais Fernandes
SpeakerMichael Ehrenstein
AI in Systemic Autoimmmunes Flare predictionSpeakerArnaud Laurent
SLE Today: Clinical Precision Through Digital Phenotyping
SpeakerAntónio Lamas
A Clinical Look | Clinical Hands-On - Flare Prediction: 3 real-life cases and what we would have done differentlySpeakerTomas Fonseca
A Clinical Look | Clinical Hands-On - Flare Prediction: 3 real-life cases and what we would have done differentlyGraziela Carvalheiras
Graziela Carvalheiras, M.D.
Assistente Hospitalar Graduada Medicina Interna
Gestora Clinica da consulta de Doenças Autoimunes
Coordenadora do Coorte de Síndrome Antifosfolipídeo
Unidade de Imunologia Clinica, ULSSA- Hospital Santo António
Jorge Manuel Santos Fortuna
Antonio Alexandre Morais Fernandes
Michael Ehrenstein
Professor Michael Ehrenstein leads a research group focused on advancing personalised medicine in systemic lupus erythematosus by identifying which patients are most likely to benefit from specific therapies. He was Chief Investigator for the BEAT‑LUPUS trial, one of the first studies to evaluate combination biologic therapy using rituximab followed by belimumab in SLE. Analysis of samples from BEAT‑LUPUS, integrating multi‑omic data with machine‑learning approaches, identified a predictive biomarker for response to this treatment sequence. This is now being prospectively evaluated in the STRATIFY Lupus trial—the first biomarker‑enrichment study in SLE, funded by Arthritis UK and NIHR EME, with belimumab provided by GSK. His group has also recently identified an autoantibody‑defined lupus subgroup with distinct inflammatory features and poorer outcomes following B‑cell‑depleting therapy, further supporting the development of stratified treatment approaches.
Arnaud Laurent
Pr Laurent ARNAUD, MD, PhD.
Laurent.arnaud@chru-strasbourg.fr
X acccount: @LupusreferenceLaurent ARNAUD (MD, PhD) is full Professor of Rheumatology at Strasbourg University & Academic Hospitals, France. His main clinical interests focus on patient-centered care of those living with Systemic Lupus Erythematosus (SLE). He is leading an international research network focusing on innovative strategies for holistic SLE care using novel diagnostic and therapeutic digital strategies. With his team at the French National Reference Center for Rare Autoimmune Diseases of Strasbourg (CRMR RESO), he has published >300 articles in the field of rare diseases and is currently leading several international taskforces and actions for SLE. Professor Arnaud is the Past-President of the European Lupus Society (SLEuro) and is Elected Member of the Strategic board of the European Reference Network for rare diseases ReCONNET. He is also the curator of an X account (@Lupusreference) about lupus education, followed by >19k people.
António Lamas
Tomas Fonseca
-
10:30-11:00
30 min
Coffee-Break
-
11:00-13:00 - Auditorium
120 min
PRECISION AND PREDICTION IN CLINICAL PRACTICE
Session 5: Immunogenetics and Personalized Therapy
ChairsManuel Nuno Vital Mendes Riso
ChairsBerta Martins
ChairsIsabel Almeida
SpeakerHugo Filipe De Mesquita Costa Martiniano
Polygenic Risk Scores in Clinical PracticeSpeakerJoão Gonçalves
Pharmacogenomics in Biologic SelectionSpeakerBárbara Guerra Leal
HLA-Based Stratification for Treatment ResponseSpeakerMarta Isabel Rodrigues Casal Moura
A Clinical Look | Clinical Hands-On - Rapid therapeutic stratification: an algorithm for biologicManuel Nuno Vital Mendes Riso
SÚMULA CURRICULAR
Nuno Riso, Chefe de Serviço de Medicina Interna
Desenvolveu a sua principal atividade profissional durante 40 anos nos Hospitais Civis de Lisboa atualmente designados como Unidade Local de Saúde S. José, maioritariamente no Hospital de Curry Cabral passando por todos os graus da carreira hospitalar, tendo ultimamente exercido o cargo de Diretor do Serviço7.2. de Medicina Interna. Aposentado da função pública em agosto de 2015.
Exerce clínica em consultório privado em Lisboa desde 1986.
Membro fundador do Núcleo de Estudos de Doenças Auto-Imunes da Sociedade Portuguesa de Medicina Interna, tendo sido seu responsável durante 10 anos e responsável da Unidade de Doenças Auto-Imunes do Hospital de Curry Cabral.
Foi Diretor do Internato Médico dos Hospitais Civis de Lisboa e do Hospital de Curry Cabral, e Presidente da Comissão Regional do Internato Médico da Zona Sul.
Foi ainda Prof. Auxiliar Convidado da Nova Medical School- Faculdade de Ciências Médicas da Universidade Nova de Lisboa.
Realizou o Curso de Formação em Codificação Clínica da Escola Nacional de Saúde Pública
Realizou uma Pós-Graduação em Gestão de Unidades de Saúde da Universidade Católica Portuguesa.
Realizou o Curso de Medicina do Trabalho da Escola Nacional de Saúde Publica.
Berta Martins
Isabel Almeida
Hugo Filipe De Mesquita Costa Martiniano
João Gonçalves
Bárbara Guerra Leal
Marta Isabel Rodrigues Casal Moura
-
13:00-14:00
60 min
Lunch Break
-
14:00-14:15 - Auditorium
15 min
PRECISION AND PREDICTION IN CLINICAL PRACTICE
Acknowledge and thanking who are leaving UIC (Unidade de Imunologia Clinica)
SpeakersAntónio Marinho
SpeakersCarlos Vasconcelos
António Marinho
Carlos Vasconcelos
-
14:15-16:00 - Auditorium
105 min
PRECISION AND PREDICTION IN CLINICAL PRACTICE
Laboratory Immunology in the Precision Medicine Era
ChairsMaria José Rêgo De Sousa
ChairsDulce Martins
SpeakerJan Damoiseaux
Multiplex in the era of precision medicine: information overload or a useful piece of the autoimmunity puzzleSpeakerAna Margarida Da Cruz Albuquerque
Genomics and the gut microbiome: building the architecture of precision autoimmunityMaria José Rêgo De Sousa
Dulce Martins
Jan Damoiseaux
Ana Margarida Da Cruz Albuquerque
-
16:00-16:30
30 min
Coffee-Break
-
16:30-17:45 - Auditorium
75 min
PRECISION AND PREDICTION IN CLINICAL PRACTICE
SLE Round-table
ChairManuel Carlos Dias
ChairAntónio Marinho
ChairCarlos Vasconcelos
SpeakersAntónio Marinho
SpeakersAntónio Lamas
SpeakersIvo Santos Barreiro
SpeakersRaquel Faria
Manuel Carlos Dias
António Marinho
Carlos Vasconcelos
António Lamas
Ivo Santos Barreiro
Assistente Hospitalar de Medicina Interna da Unidade Local de Saúde de Santo António
Membro da Unidade de Imunologia Clínica da Unidade Local de Saúde de Santo António
Co-responsável da coorte de Doença de Sjögren da Unidade de Imunologia Clínica (ERN ReCONNET)
Co-responsável da Consulta Multidisciplinar de Uveítes Imunomediadas
Docente Externo da Unidade Curricular Imunologia Clínica do Instituto de Ciências Biomédicas Abel Salazar da Universidade do Porto
Raquel Faria
-
08:00-08:56 - Auditorium
56 min
Short Oral Communications
Autoimmune Diseases (5); Rheumatoid Arthritis (1)
ChairsBruno Grima
ChairsAndre Miguel Neto Real
ChairsTeresa Maria Melim Faria
AuthorJéssica Oliveira
CO07 - (2185) - ANTI-SAE DERMATOMYOSITIS WITH ORGANIZING PNEUMONIA IN AN ELDERLY PATIENT
AuthorCátia Baptista
CO08 - (2186) - THALAMIC ISCHEMIA IN ANTIPHOSPHOLIPID SYNDROME: A RARE PRESENTATION
AuthorCatarina Coelho Faria
CO09 - (2187) - AN UNUSUAL AUTOIMMUNE TRIAD: SLE, SJÖGREN’S DISEASE AND RELAPSING POLYCHONDRITIS
AuthorSara Dourado
CO10 - (2188) - BEYOND SARCOIDOSIS: AN UNEXPECTED DIAGNOSIS OF PRIMARY SCLEROSING CHOLANGITIS
AuthorSara Dourado
CO11 - (2189) - WHEN ELEVATED IGG4 MISLEADS: A DIAGNOSTIC ODYSSEY TO CASTLEMAN DISEASE
AuthorMafalda Santos
CO12 - (2190) - LUNG NODULES IN RHEUMATOID ARTHRITIS. A DISEASE OR A THERAPEUTIC COMPLICATION?Bruno Grima
Andre Miguel Neto Real
Assistente Hospitalar Graduado em Medicina Interna.
Assistente Hospitalar em Medicina Intensiva.
Coordenador da Unidade de Doenças Autoimunes da ULS Médio Tejo - Abrantes
Teresa Maria Melim Faria
Jéssica Oliveira
Cátia Baptista
Catarina Coelho Faria
Sara Dourado
Sara Dourado
Mafalda Santos
-
09:00-10:30 - Auditorium
90 min
PRECISION AND PREDICTION IN CLINICAL PRACTICE
Session 4: Biomarkers and digital monitoring
ChairGraziela Carvalheiras
ChairJorge Manuel Santos Fortuna
ChairAntonio Alexandre Morais Fernandes
SpeakerMichael Ehrenstein
AI in Systemic Autoimmmunes Flare predictionSpeakerArnaud Laurent
SLE Today: Clinical Precision Through Digital Phenotyping
SpeakerAntónio Lamas
A Clinical Look | Clinical Hands-On - Flare Prediction: 3 real-life cases and what we would have done differentlySpeakerTomas Fonseca
A Clinical Look | Clinical Hands-On - Flare Prediction: 3 real-life cases and what we would have done differentlyGraziela Carvalheiras
Graziela Carvalheiras, M.D.
Assistente Hospitalar Graduada Medicina Interna
Gestora Clinica da consulta de Doenças Autoimunes
Coordenadora do Coorte de Síndrome Antifosfolipídeo
Unidade de Imunologia Clinica, ULSSA- Hospital Santo António
Jorge Manuel Santos Fortuna
Antonio Alexandre Morais Fernandes
Michael Ehrenstein
Professor Michael Ehrenstein leads a research group focused on advancing personalised medicine in systemic lupus erythematosus by identifying which patients are most likely to benefit from specific therapies. He was Chief Investigator for the BEAT‑LUPUS trial, one of the first studies to evaluate combination biologic therapy using rituximab followed by belimumab in SLE. Analysis of samples from BEAT‑LUPUS, integrating multi‑omic data with machine‑learning approaches, identified a predictive biomarker for response to this treatment sequence. This is now being prospectively evaluated in the STRATIFY Lupus trial—the first biomarker‑enrichment study in SLE, funded by Arthritis UK and NIHR EME, with belimumab provided by GSK. His group has also recently identified an autoantibody‑defined lupus subgroup with distinct inflammatory features and poorer outcomes following B‑cell‑depleting therapy, further supporting the development of stratified treatment approaches.
Arnaud Laurent
Pr Laurent ARNAUD, MD, PhD.
Laurent.arnaud@chru-strasbourg.fr
X acccount: @LupusreferenceLaurent ARNAUD (MD, PhD) is full Professor of Rheumatology at Strasbourg University & Academic Hospitals, France. His main clinical interests focus on patient-centered care of those living with Systemic Lupus Erythematosus (SLE). He is leading an international research network focusing on innovative strategies for holistic SLE care using novel diagnostic and therapeutic digital strategies. With his team at the French National Reference Center for Rare Autoimmune Diseases of Strasbourg (CRMR RESO), he has published >300 articles in the field of rare diseases and is currently leading several international taskforces and actions for SLE. Professor Arnaud is the Past-President of the European Lupus Society (SLEuro) and is Elected Member of the Strategic board of the European Reference Network for rare diseases ReCONNET. He is also the curator of an X account (@Lupusreference) about lupus education, followed by >19k people.
António Lamas
Tomas Fonseca
-
11:00-13:00 - Auditorium
120 min
PRECISION AND PREDICTION IN CLINICAL PRACTICE
Session 5: Immunogenetics and Personalized Therapy
ChairsManuel Nuno Vital Mendes Riso
ChairsBerta Martins
ChairsIsabel Almeida
SpeakerHugo Filipe De Mesquita Costa Martiniano
Polygenic Risk Scores in Clinical PracticeSpeakerJoão Gonçalves
Pharmacogenomics in Biologic SelectionSpeakerBárbara Guerra Leal
HLA-Based Stratification for Treatment ResponseSpeakerMarta Isabel Rodrigues Casal Moura
A Clinical Look | Clinical Hands-On - Rapid therapeutic stratification: an algorithm for biologicManuel Nuno Vital Mendes Riso
SÚMULA CURRICULAR
Nuno Riso, Chefe de Serviço de Medicina Interna
Desenvolveu a sua principal atividade profissional durante 40 anos nos Hospitais Civis de Lisboa atualmente designados como Unidade Local de Saúde S. José, maioritariamente no Hospital de Curry Cabral passando por todos os graus da carreira hospitalar, tendo ultimamente exercido o cargo de Diretor do Serviço7.2. de Medicina Interna. Aposentado da função pública em agosto de 2015.
Exerce clínica em consultório privado em Lisboa desde 1986.
Membro fundador do Núcleo de Estudos de Doenças Auto-Imunes da Sociedade Portuguesa de Medicina Interna, tendo sido seu responsável durante 10 anos e responsável da Unidade de Doenças Auto-Imunes do Hospital de Curry Cabral.
Foi Diretor do Internato Médico dos Hospitais Civis de Lisboa e do Hospital de Curry Cabral, e Presidente da Comissão Regional do Internato Médico da Zona Sul.
Foi ainda Prof. Auxiliar Convidado da Nova Medical School- Faculdade de Ciências Médicas da Universidade Nova de Lisboa.
Realizou o Curso de Formação em Codificação Clínica da Escola Nacional de Saúde Pública
Realizou uma Pós-Graduação em Gestão de Unidades de Saúde da Universidade Católica Portuguesa.
Realizou o Curso de Medicina do Trabalho da Escola Nacional de Saúde Publica.
Berta Martins
Isabel Almeida
Hugo Filipe De Mesquita Costa Martiniano
João Gonçalves
Bárbara Guerra Leal
Marta Isabel Rodrigues Casal Moura
-
14:00-14:15 - Auditorium
15 min
PRECISION AND PREDICTION IN CLINICAL PRACTICE
Acknowledge and thanking who are leaving UIC (Unidade de Imunologia Clinica)
SpeakersAntónio Marinho
SpeakersCarlos Vasconcelos
António Marinho
Carlos Vasconcelos
-
14:15-16:00 - Auditorium
105 min
PRECISION AND PREDICTION IN CLINICAL PRACTICE
Laboratory Immunology in the Precision Medicine Era
ChairsMaria José Rêgo De Sousa
ChairsDulce Martins
SpeakerJan Damoiseaux
Multiplex in the era of precision medicine: information overload or a useful piece of the autoimmunity puzzleSpeakerAna Margarida Da Cruz Albuquerque
Genomics and the gut microbiome: building the architecture of precision autoimmunityMaria José Rêgo De Sousa
Dulce Martins
Jan Damoiseaux
Ana Margarida Da Cruz Albuquerque
-
16:30-17:45 - Auditorium
75 min
PRECISION AND PREDICTION IN CLINICAL PRACTICE
SLE Round-table
ChairManuel Carlos Dias
ChairAntónio Marinho
ChairCarlos Vasconcelos
SpeakersAntónio Marinho
SpeakersAntónio Lamas
SpeakersIvo Santos Barreiro
SpeakersRaquel Faria
Manuel Carlos Dias
António Marinho
Carlos Vasconcelos
António Lamas
Ivo Santos Barreiro
Assistente Hospitalar de Medicina Interna da Unidade Local de Saúde de Santo António
Membro da Unidade de Imunologia Clínica da Unidade Local de Saúde de Santo António
Co-responsável da coorte de Doença de Sjögren da Unidade de Imunologia Clínica (ERN ReCONNET)
Co-responsável da Consulta Multidisciplinar de Uveítes Imunomediadas
Docente Externo da Unidade Curricular Imunologia Clínica do Instituto de Ciências Biomédicas Abel Salazar da Universidade do Porto
Raquel Faria
-
09:00-10:45 - Auditorium
105 min
INNOVATION AND INTEGRATION
Session 6: New Frontiers in Therapy
ChairIvone Melo Valadão
ChairLuís Manuel Barreto Campos
SpeakerAfonso R.M. Almeida
CAR-T Cells in AutoimmunitySpeakerHelena Isabel Fialho Florindo Roque Ferreira
Nanomedicine and Targeted Delivery toward "tolerogenesis"SpeakerAfonso R.M. Almeida
When to consider advanced therapies (CAR-T, tolerogenic, nanomedicine) Interview with allSpeakerHelena Isabel Fialho Florindo Roque Ferreira
When to consider advanced therapies (CAR-T, tolerogenic, nanomedicine) Interview with allIvone Melo Valadão
Luís Manuel Barreto Campos
Luís Campos é médico internista, fundador e presidente do Conselho Português para a Saúde e Ambiente, comissário do Plano Nacional de Saúde 2021-2030 e presidente do Comité de Qualidade de Cuidados e Assuntos Profissionais da Federação Europeia de Medicina Interna. Entre outras funções anteriores, foi coordenador para os cuidados hospitalares do Grupo de Apoio à Implementação de Políticas de Saúde do Ministério da Saúde, diretor dos Serviços de Medicina Interna e de Urgência do Hospital São Francisco Xavier, professor da NOVA Medical School, presidente da Sociedade Portuguesa de Medicina Interna (SPMI), presidente do Conselho Nacional para a Qualidade em Saúde, coordenador nacional do Registo de Saúde Eletrónico, coordenador nacional do Grupo de Estudos de Autoimunidade da SPMI e conselheiro dos Governos Regionais de Macau e Açores. Luis Campos apresentou mais de 600 conferências, foi autor ou coautor de cerca de 340 comunicações, dezenas de publicações e 16 capítulos de livros. Foi coeditor de dois livros. É Honorary Fellow do American College of Physicians e Fellow da European Federation of Internal Medicine. Recebeu o Prémio Nacional de Medicina Interna em 2024.
Afonso R.M. Almeida
Helena Isabel Fialho Florindo Roque Ferreira
Helena Florindo graduated in Pharmaceutical Sciences in 2003 (University of Lisbon) and obtained her Ph.D. degree in Pharmaceutical Technology in 2008 (University of Lisbon), in collaboration with the University of London. Currently, she is a Full Professor in the Department of Pharmacy, Pharmacology, and Health Technologies, and a Vice-Dean at the Faculty of Pharmacy, University of Lisbon. Since 2015, she has been the head of the BioNanoSciences – Drug Delivery & Immunoengineering Research Group, at the Research Institute for Medicines (iMed.ULisboa), University of Lisbon. Helena is also a member of the Portuguese Medicines Agency Evaluation Board (INFARMED), thus supporting the evaluation of marketing authorization procedures for new drugs and biologics. This knowledge in regulatory sciences also guides the research within her research group, which has been focused on the rational development of functionalized nanomaterials as new therapies or vaccines for infectious diseases and cancer. It includes the characterization of the anti-tumor effects induced by the combination of nano-vaccines with nano-therapeutics designed to modulate the functions of key cells within the tumor microenvironment, such as T cells, myeloid-derived cells, and tumor cells.
-
10:15-10:45
30 min
Coffee-Break
-
10:45-12:00 - Auditorium
75 min
INNOVATION AND INTEGRATION
Immunodeficiencies induced by immunosuppressive therapies: when and how to treat?
SpeakerAntónio Marinho
António Marinho
-
11:30-12:30 - Auditorium
60 min
INNOVATION AND INTEGRATION
Closing Keynote - Autoimmunity in the Age of Convergence: Tech, Data, and Humanity
SpeakerAntónio Coutinho
ChairsCarlos Vasconcelos
ChairsCarlos Alberto Monteiro Silva Ferreira
António Coutinho
Carlos Vasconcelos
Carlos Alberto Monteiro Silva Ferreira
Ex. Senior Graduate Hospital Physician in Internal Medicine at Hospital de Santa Maria Lisbon
PhD in ( Lupus Erythematosus) made on the Faculty of Medicine of the University of Lisbon in collaboration with the Immunology Unit of the Pasteur de Paris Institute, with the advisor to Professor Antonio Coutinho.
Assistant Professor Guest of Lisbon School of Medicine (retiree).
Ex. responsible for the autoimmune disorder outpatients (MedicineII) at Hospital de Santa Maria, Lisbon.
Ex. researcher of the Clinical Immunology Unit, the Institute of Molecular Medicine of the Lisbon School of Medicine.
Ex. cooperator with the Gulbenkian Institute of Science in the field of autoimmunity.
Founding member of the Core of Autoimmune Disease Studies of the Portuguese Internal Medicine Society.
Founding member of the Portuguese Association of Lupus Patients
Former vice-President of the Portuguese Society of Internal Medicine.
-
12:30-13:00 - Auditorium
30 min
Closing Ceremony | Presentation of Awards
-
09:00-10:45 - Auditorium
105 min
INNOVATION AND INTEGRATION
Session 6: New Frontiers in Therapy
ChairIvone Melo Valadão
ChairLuís Manuel Barreto Campos
SpeakerAfonso R.M. Almeida
CAR-T Cells in AutoimmunitySpeakerHelena Isabel Fialho Florindo Roque Ferreira
Nanomedicine and Targeted Delivery toward "tolerogenesis"SpeakerAfonso R.M. Almeida
When to consider advanced therapies (CAR-T, tolerogenic, nanomedicine) Interview with allSpeakerHelena Isabel Fialho Florindo Roque Ferreira
When to consider advanced therapies (CAR-T, tolerogenic, nanomedicine) Interview with allIvone Melo Valadão
Luís Manuel Barreto Campos
Luís Campos é médico internista, fundador e presidente do Conselho Português para a Saúde e Ambiente, comissário do Plano Nacional de Saúde 2021-2030 e presidente do Comité de Qualidade de Cuidados e Assuntos Profissionais da Federação Europeia de Medicina Interna. Entre outras funções anteriores, foi coordenador para os cuidados hospitalares do Grupo de Apoio à Implementação de Políticas de Saúde do Ministério da Saúde, diretor dos Serviços de Medicina Interna e de Urgência do Hospital São Francisco Xavier, professor da NOVA Medical School, presidente da Sociedade Portuguesa de Medicina Interna (SPMI), presidente do Conselho Nacional para a Qualidade em Saúde, coordenador nacional do Registo de Saúde Eletrónico, coordenador nacional do Grupo de Estudos de Autoimunidade da SPMI e conselheiro dos Governos Regionais de Macau e Açores. Luis Campos apresentou mais de 600 conferências, foi autor ou coautor de cerca de 340 comunicações, dezenas de publicações e 16 capítulos de livros. Foi coeditor de dois livros. É Honorary Fellow do American College of Physicians e Fellow da European Federation of Internal Medicine. Recebeu o Prémio Nacional de Medicina Interna em 2024.
Afonso R.M. Almeida
Helena Isabel Fialho Florindo Roque Ferreira
Helena Florindo graduated in Pharmaceutical Sciences in 2003 (University of Lisbon) and obtained her Ph.D. degree in Pharmaceutical Technology in 2008 (University of Lisbon), in collaboration with the University of London. Currently, she is a Full Professor in the Department of Pharmacy, Pharmacology, and Health Technologies, and a Vice-Dean at the Faculty of Pharmacy, University of Lisbon. Since 2015, she has been the head of the BioNanoSciences – Drug Delivery & Immunoengineering Research Group, at the Research Institute for Medicines (iMed.ULisboa), University of Lisbon. Helena is also a member of the Portuguese Medicines Agency Evaluation Board (INFARMED), thus supporting the evaluation of marketing authorization procedures for new drugs and biologics. This knowledge in regulatory sciences also guides the research within her research group, which has been focused on the rational development of functionalized nanomaterials as new therapies or vaccines for infectious diseases and cancer. It includes the characterization of the anti-tumor effects induced by the combination of nano-vaccines with nano-therapeutics designed to modulate the functions of key cells within the tumor microenvironment, such as T cells, myeloid-derived cells, and tumor cells.
-
10:45-12:00 - Auditorium
75 min
INNOVATION AND INTEGRATION
Immunodeficiencies induced by immunosuppressive therapies: when and how to treat?
SpeakerAntónio Marinho
António Marinho
-
11:30-12:30 - Auditorium
60 min
INNOVATION AND INTEGRATION
Closing Keynote - Autoimmunity in the Age of Convergence: Tech, Data, and Humanity
SpeakerAntónio Coutinho
ChairsCarlos Vasconcelos
ChairsCarlos Alberto Monteiro Silva Ferreira
António Coutinho
Carlos Vasconcelos
Carlos Alberto Monteiro Silva Ferreira
Ex. Senior Graduate Hospital Physician in Internal Medicine at Hospital de Santa Maria Lisbon
PhD in ( Lupus Erythematosus) made on the Faculty of Medicine of the University of Lisbon in collaboration with the Immunology Unit of the Pasteur de Paris Institute, with the advisor to Professor Antonio Coutinho.
Assistant Professor Guest of Lisbon School of Medicine (retiree).
Ex. responsible for the autoimmune disorder outpatients (MedicineII) at Hospital de Santa Maria, Lisbon.
Ex. researcher of the Clinical Immunology Unit, the Institute of Molecular Medicine of the Lisbon School of Medicine.
Ex. cooperator with the Gulbenkian Institute of Science in the field of autoimmunity.
Founding member of the Core of Autoimmune Disease Studies of the Portuguese Internal Medicine Society.
Founding member of the Portuguese Association of Lupus Patients
Former vice-President of the Portuguese Society of Internal Medicine.
-
12:30-13:00 - Auditorium
30 min
Closing Ceremony | Presentation of Awards
The PAM – Porto’s Autoimmune Meeting, Porto, Portugal 13/11/2025 – 15/11/2025PAM – Porto’s Autoimmune Meeting, Porto, Portugal 13/11/2025 – 15/11/2025 , has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 16.016.0 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.
Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at https://edhub.ama-assn.org/pages/applications .
Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.
